Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CADU, a cloud-enabled AI solution created by Odin Vision, is designed to aid in identifying and characterizing dysplasia in individuals with Barrett’s oesophagus during gastroscopy. The system evaluates areas that visually resemble Barrett’s oesophagus and offers insights to help clinicians determine whether the tissue is dysplastic or non-dysplastic. By improving the decision-making process for endoscopists and expediting the examination of the oesophagus, CADU proves to be both time-efficient and cost-effective. Additionally, it functions on a platform that is vendor-neutral, facilitating its use with various endoscopic equipment. The system is CE marked and holds UKCA approval; however, it is not available for commercial sale in the United States. CADU has been adopted in clinical environments, including University College London Hospitals, aiming to enhance the detection of early oesophageal cancer, which can often be difficult to identify due to the subtle nature of initial lesions. Its implementation represents a significant advancement in the early diagnosis of this serious condition, highlighting the importance of technology in modern medicine.
Description
Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Odin Vision
Country
United Kingdom
Website
odin-vision.com/en_gb/cadu-2/
Vendor Details
Company Name
Paige
Country
United States
Website
paige.ai/
Product Features
Medical Imaging
Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management